Investment Summary |
|
|---|---|
| Date | 2016-10-18 |
| Target | Eywa Pharma |
| Sector | Life Science |
| Investor(s) | Eight Roads |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1969 |
| PE ASSETS | 11.0B USD |
| Size | Mega |
| Type | Sector Focused |
Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 131 of 293 |
| Sector: Life Science M&A | 38 of 73 |
| Type: Venture M&A Deals | 111 of 266 |
| Country: Singapore M&A | 2 of 4 |
| Year: 2016 M&A | 18 of 22 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-10-14 |
Snapsheet
Chicago, Illinois, United States Snapsheet is the pioneering provider of virtual claims technology to leading auto insurance carriers. Snapsheet's Virtual Insurance Claims Exchange platform optimizes the estimation process for auto repairs from customer photo submission to efficient estimate processing to final repairs and payment. Snapsheet was founded in 2011 and is based in Chicago, Illinois. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-11-02 |
Turnstone Biologics
Ottawa, Ontario, Canada Turnstone Biologics is a clinical-stage biotech company, is developing breakthrough cancer immunotherapies by advancing two leading and complementary platforms that drive innate and adaptive tumor immunity, to provide benefit to the millions of cancer patients underserved by current treatment options. Turnstone Biologics was founded in 2015 and is based in Ottawa, Ontario. |
Buy | - |
